No products in the cart.

We deliver to:

🇦🇺 Australia

🇧🇪 Belgium

🇨🇦 Canada

🇨🇿 Czechia

🇩🇰 Denmark

🇪🇪 Estonia

🇫🇮 Finland

🇬🇷 Greece

🇭🇺 Hungary

🇮🇪 Ireland

🇮🇱 Israel

🇮🇹 Italy

🇯🇵 Japan

🇰🇼 Kuwait

🇱🇻 Latvia

🇱🇹 Lithuania

🇲🇽 Mexico

🇲🇩 Moldova

🇳🇱 Netherlands

🇳🇴 Norway

🇵🇱 Poland

🇷🇴 Romania

🇸🇰 Slovakia

🇰🇷 South Korea

🇨🇭 Switzerland

🇬🇧 United Kingdom

🇺🇸 United States of America

and more

  • Derylife
  • Derylife
Please note: The product packaging may vary from the images shown. The contents, ingredients, and quality of the product remain unchanged.

Derylife cream 0.5 mg/g tube 50 g

$27.54

*All prices are in US dollars (USD)

Free Worldwide Shipping

to: Australia, Belgium, Canada, Czechia, Denmark, Estonia, Finland, Greece, Hungary, Ireland, Israel, Italy, Japan, Kuwait, Latvia, Lithuania, Mexico, Moldova, Netherlands, Norway, Poland, Romania, Slovakia, South Korea, Switzerland, United Kingdom, United States and more

🏖️ Hello! We are on vacation!

We are still accepting orders on our website; however, order processing and shipping will resume after September 10. If you place an order during our vacation, we will contact you and remind you about the temporary shipping delay. Starting September 10, all orders received during this period will be processed and shipped in the order they were placed. If your order contains a product with less than one year remaining before its expiration date, we will notify you after September 10 and proceed according to your instructions. If you decide to cancel an order placed during our vacation, simply contact us through the contact form on our website, and we will be happy to assist you. Thank you for your understanding, and we apologize for any inconvenience caused.

In stock

Derylife clobetasol cream for short-term treatment of psoriasis, lichen planus and other steroid-sensitive dermatoses. Adults and children over 1 year.

Categories: Brand:
Can’t find it? Ask us via WhatsApp, Telegram, Viber or chat

Payment

PayPal, Debit or Credit card, Google Pay, Apple Pay

or

Orders Temporarily Unavailable

Due to temporary postal service disruptions, we are currently unable to accept orders.

Derylife is a highly active topical corticosteroid used in adults, the elderly, and children over 1 year of age only for short-term treatment of relatively more persistent inflammatory and pruritic manifestations of steroid-sensitive dermatoses that are insensitive to less active corticosteroids.

Such diseases are:

  • psoriasis (except widespread plaque psoriasis);
  • dermatoses that are difficult to treat;
  • red lichen planus;
  • discoid lupus erythematosus;
  • other skin diseases that are not treatable with less active corticosteroids.

Composition

  • active ingredient: clobetasol;
  • 1 g of cream contains clobetasol propionate 0.5 mg;
  • excipients: white wax; propylene glycol; chlorocresol; polyethylene glycol (macrogol) cetostearyl ether; polyethoxylated hydrogenated castor oil; polyethylene glycol (macrogol) hydroxystearate; cetostearyl alcohol; purified water.

Contraindication

  • Hypersensitivity to the active substance and/or to the excipients of the medicinal product.
  • Untreated skin infections.
  • Rosacea.
  • Common acne.
  • Itching without inflammation.
  • Perianal and genital itching.
  • Perioral dermatitis.
  • Dermatoses in children under 1 year of age, including dermatitis and diaper rash.

Method of application

Clobetasol propionate belongs to the class of the most potent topical corticosteroids (Group IV), and prolonged use may result in serious adverse effects. If treatment with a topical corticosteroid is clinically warranted after 4 weeks, a less potent corticosteroid should be considered. Repeated but short courses of clobetasol propionate may be used to control flare-ups.

The medicine is intended for topical (cutaneous) use.

Especially suitable for treating moist and weeping areas of skin.

The cream should be applied gently in a thin layer, covering all affected areas of the skin, 1 or 2 times a day until clinical improvement occurs (if there is a good response to treatment, improvement is achieved in a few days), then reduce the frequency of application or change to a less potent preparation. After each application of the cream, wait a certain time until it is completely absorbed before applying an emollient. In case of worsening or no improvement in clinical manifestations within 2-4 weeks, the diagnosis and treatment should be reviewed.

The maximum weekly dose should not exceed 50 g.

Application features

Use during pregnancy or breastfeeding

Data on the use of topical clobetasol in pregnant women are limited.

The minimum amount of the drug should be used for the minimum duration of treatment.

The safety of clobetasol during breastfeeding has not been established. The drug can be used during breastfeeding only if the expected benefit to the woman outweighs the risk to the child.

Children

The drug is contraindicated for the treatment of dermatoses, including dermatitis, in children under 1 year of age.

Ability to influence reaction speed when driving vehicles or other mechanisms

No studies have been conducted to study this effect. Given the adverse reaction profile of clobetasol, no effect on the reaction speed when driving or using other mechanisms is expected.

Overdose

With normal use, the cream can be absorbed in quantities sufficient to cause systemic effects. The likelihood of an acute overdose is very small, however, in case of chronic overdose or improper use, signs of hypercortisolism may occur.

Treatment.

In case of overdose, it should be gradually discontinued by reducing the frequency of cream application or replacing it with a less potent corticosteroid due to the risk of glucocorticosteroid insufficiency.

Further treatment should be based on the patient’s clinical condition or national guidelines for the treatment of poisoning, if available.

Adverse reactions

Infections and infestations: very rare – opportunistic infections.

On the part of the immune system: very rarely – local hypersensitivity.

On the part of the endocrine system: very rarely – suppression of the hypothalamic-pituitary-adrenal system: Cushingoid features (e.g., moon face, central obesity), delayed weight gain/growth in children, osteoporosis, glaucoma, hyperglycemia/glucosuria, cataracts, arterial hypertension, weight gain/obesity, decreased endogenous cortisol levels, alopecia, hair fragility.

On the part of the organs of vision: frequency unknown – impaired visual acuity.

Interaction with other medicinal products and other types of interactions

Concomitant use with drugs that may inhibit CYP3A4 (e.g. ritonavir, itraconazole) has been shown to inhibit the metabolism of corticosteroids, which may result in increased systemic exposure. The extent to which this interaction is clinically significant depends on the dose, route of administration of the corticosteroid, and the potency of the CYP3A4 inhibitor.

Storage conditions

Store at a temperature not exceeding 25 ºС in a place inaccessible to children.

Reviews

There are no reviews yet.

Be the first to review “Derylife cream 0.5 mg/g tube 50 g”

Your email address will not be published. Required fields are marked